$ 30.00

MORE INFO

preview

State of the Art in Case Management: 2018 & Beyond

Toni Cesta, Ph.D., RN, FAAN and Beverly Cunningham, MS, RN
  • Duration: 1h 30m

  • Ref. 191945

Case management is found across the continuum of care, most recently returning to the community where its roots began. This program will review where case management came from and how it will work in today’s managed care and government payer environments. This webinar will review Medicare’s latest programs that impact the rol....

$ 30.00

MORE INFO

preview

Infection Prevention and Control - Level 1

Rowena Chilvers, Jo Green, Helen Dunn, Deborah Tyler, Mohamed Sadak, Esther Taborn.
  • Duration: 1h

  • Ref. 195281

This e-learning session meets the statutory and mandatory training requirements and learning outcomes for Infection Prevention and Control Level 1 in the UK Core Skills Training Framework (UK CSTF).

$ 37.00

MORE INFO

preview

SIP Core Integration Seminar 3: Communication: Pitfalls and Clearing Exercises

Jim Morningstar, PhD
  • Duration: 2h 15m

  • Ref. 167091

3.00 Hours

Knowing how to recognize "Risky Rascals," those commonly used messages that purport to help, but which enmesh communicators emotional systems is key to assisting self and others to increase clarity and effectiveness. Recognizing communication styles and redirecting ineffective styles is the second goal of this seminar.

$ 27.00

MORE INFO

preview

SIP Core Integration Seminar 4: Therapeutic Breathwork Introduction

Jim Morningstar, PhD
  • Duration: 1h 15m

  • Ref. 167106

2.00 Hours

The basic elements of therapeutic breathwork that has been developed since the 1970's and applied to areas of therapy, medicine and spiritual growth is presented through audio download and class text, "Breathing in Light and Love, Milwaukee, WI: Transformations Incorporated, 1994, by Jim Morningstar." Practitioners will be intro....

$ 30.59

MORE INFO

preview

Understanding Dementia 2 - Person Centred Care

e3Learning
  • Duration: 1h

  • Ref. 176362

This course has been developed to help the learner provide person centred care that is tailored to the individual needs of people suffering from dementia.

$ 41.54

MORE INFO

preview

Weaning from Mechanical Ventilation

Gareth Hughes
  • Duration: 1h

  • Ref. 188646

This session describes the process of weaning from mechanical ventilation, the pathophysiology that affects the success of weaning and the predictors of weaning success and failure. It also describes weaning techniques and the role of tracheostomy and non-invasive ventilation.

$ 30.00

MORE INFO

preview

Emotional Support and Signposting

David McCracken
  • Duration: 30m

  • Ref. 191976

This session will help you to understand the skills required to communicate effectively with individuals and families affected by bereavement, demonstrating empathy and signposting to other services where appropriate.

$ 30.00

MORE INFO

preview

Moving and Handling Level 1

National Health England
  • Duration: 30m

  • Ref. 194884

Moving and handling can be a frequent activity for many employees. In health and social care, moving and handling injuries account for 40% of work-related sickness absence. Around 5000 moving and handling injuries are reported each year in health services.

$ 39.95

MORE INFO

preview

Wound Care for Health Providers

Deborah Zaricor: MSN, RN, CWOCN, WOC
  • Duration: 5h

  • Ref. 148369

5.00 Hours

This online self-study course is designed to provide health providers with the most up-to-date tools to allow delivery of successful treatment plans for wound healing and will refresh you on the very basic form of clinical practice, which is tending the wounds of the patients.

Verbal De-escalation Techniques

Oluwatoni Idowu and David Keen
  • Duration: 1h

  • Ref. 199685

This session introduces verbal de-escalation techniques and outlines how to integrate areas included in a safety plan in your current care plans.

Mechanisms of Action, Effectiveness and UKMEC

Ruth Bailey
  • Duration: 1h 15m

  • Ref. 199697

This session will give an overview of the contraceptive choices that are currently available and explore their effectiveness. It will outline the principles of assessment so that safe contraceptive choices can be offered using evidence-based guidance. The session will also discuss the mechanisms for initiating and switching meth....

Scorm Test 1

Mr WCEA Administrator
  • Duration: 1h

  • Ref. 199372

Test Test Test Test Test Test

Image on Exam Question

Mr WCEA Administrator
  • Duration: 15m

  • Ref. 198551

dsfgdfsgdfgsdfgfdsgfdsgdsfgdfsgdsfg

FEB 2 Webinar with exam

Mr WCEA Administrator
  • Duration: 15m

  • Ref. 198293

Course description Course description Course description Course description Course description

TEST (Same Pre-test and Exam)

Mr WCEA Administrator
  • Duration: 15m

  • Ref. 198312

Course description example

No Exam / No Pre-test

Mr WCEA Administrator
  • Ref. 199464

No Exam / No Pre-test No Exam / No Pre-test

Interstitial Lung Disease and the Acute Medical Take

Melissa Heightman
  • Duration: 15m

  • Ref. 201146

This session outlines a variety of ways in which interstitial lung disease (ILD) may present on the acute medical take.

Mechanisms Behind Haemoptysis in Bronchiectasis

Gaurav Agarwal
  • Duration: 30m

  • Ref. 201174

This session explains the mechanisms associated with haemoptysis in bronchiectasis.

Integrating Mental Health into Primary Care

Dr. Theddeus Iheanacho
  • Duration: 1h

  • Ref. 200306

The lecture will focus on potential opportunities and barriers to integrated mental health and primary care

Megaloblastic Anaemia and An Approach to Macrocytosis

Dr Shinny Alimia
  • Duration: 1h

  • Ref. 200326

To discuss the aetiology, pathophysiology, clinical features, diagnostic approach and management of megaloblastic anaemia from vitamin B12 and folate deficiency. In addition, cover an approach to macrocytosis.

Understanding and managing substance use disorders in the primary care setting

Dr Theddeus Iheanacho
  • Duration: 1h

  • Ref. 200329

Provides an overview of addiction to substances substance use disorders and the medications and therapies for substance use disorders.

The Evolving Standard of Care: Immuno-Oncology Agents for Cervical Cancer

Linda R. Duska, Haley Moss, Abimbola Farinde, Jason Welch, Annette Sophin
  • Duration: 30m

  • Ref. 201330

0.50 Hours

Although early-stage cervical cancer can be effectively treated with surgery or chemoradiotherapy, locally advanced, recurrent, or metastatic diagnoses have poor prognoses with current treatment options. Novel immuno-oncology, targeted, and combination approaches are improving outcomes for advanced disease, representing a shift....

Advances in Inflammatory Bowel Disease: Current and Emerging Strategies to Pick the Right Treatment for the Right Patient

Dermot P. McGovern, David T. Rubin, Ricardo Correa, Abimbola Farinde, Kristi Kay Orbaugh
  • Duration: 30m

  • Ref. 201345

0.50 Hours

The myriad of available therapies for inflammatory bowel disease (IBD), as well as the numerous agents under development, can create challenges in selecting the most appropriate treatment for each individual patient. In this interactive video-based discussion, expert faculty will examine strategies to accomplish this onerous....

Delivering Comprehensive Multiple Sclerosis Care Through Patient-Centered Pathways

Joseph R Berger, Aaron E Miller, Ricardo Correa, Michele B Kaufman, Kristi Kay Orbaugh
  • Duration: 30m

  • Ref. 201346

0.50 Hours

Multiple sclerosis (MS) is characterized by a large burden of symptoms, such as functional and cognitive impairments, that drastically lower quality of life for patients. Identifying and addressing these issues can be challenging as the process requires dynamic engagement and communication with patients in order to develop a tho....

Novel Therapies in DLBCL: Current and Emerging Approaches to Personalized Care

Joshua Brody, Craig Portell, Stephanie Joyce, Michele B Kaufman, Jason Welch
  • Duration: 30m

  • Ref. 201362

0.50 Hours

The treatment landscape for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) has expanded substantially in recent years, with multiple targeted and T-cell-mediated therapies recently approved with more in advanced stages of clinical development, providing both opportunities and challenges to personalizing treatment....